From Medscape General Medicine > Departments > Original Articles
Case-Control Study on Radiology Work, Medical X-ray Investigations, and Use of Cellular Telephones as Risk Factors for Brain Tumors
Posted: 05/04/2000; Medscape General Medicine. 2000;2(2) © 2000 Medscape
processing....
- Abstract and Introduction
- Materials and Methods
- Assessment of Exposure
- Statistical Methods
- Results
- Discussion
Abstract and Introduction
Abstract
Context. Ionizing radiation is a well-established risk factor for brain tumors. During recent years, microwave exposure from the use of cellular telephones has been discussed as a potential risk factor.
Objective. To determine risk factors for brain tumors.
Design. A case-control study, with exposure assessed by questionnaires.
Participants. A total of 233 currently living men and women, aged 20 to 80 years, were included. The case patients had histopathologically verified brain tumors and lived in the Uppsala-Orebro region (1994-1996) or the Stockholm region (1995-1996). Two matched controls to each case were selected from the Swedish Population Register.
Main Outcome Measures. Ionizing radiation and use of cellular telephones as risk factors for brain tumors.
Results. A total of 209 cases (90%) and 425 controls (91%) answered the questionnaire. Work as a physician yielded an odds ratio (OR) of 6.00, with a 95% confidence interval (CI) of 0.62 to 57.7. All three case patients had worked with fluoroscopy. Radiotherapy of the head and neck region yielded an OR of 3.61 (95% CI, 0.65-19.9). Medical diagnostic x-ray examination of the same area yielded an OR of 2.10 (95% CI, 1.25-3.53), with a tumor induction period of 5 years or more. Chemical industry work yielded an OR of 4.10 (95% CI, 1.25-13.4), and laboratory work yielded an OR of 3.21 (95% CI, 1.16-8.85). Ipsilateral use of cellular telephones increased the risk for tumors in the temporal, temporoparietal, and occipital lobes (OR, 2.42; 95% CI, 0.97-6.05), ie, the anatomic areas with highest exposure to microwaves from a mobile telephone. The result was further strengthened (OR, 2.62; 95% CI, 1.02-6.71) in a multivariate analysis that included laboratory work and medical diagnostic x-ray investigations of the head and neck.
Conclusion. Exposure to ionizing radiation, work in laboratories, and work in the chemical industry increased the risk of brain tumors. Use of a cellular telephone was associated with an increased risk in the anatomic area with highest exposure.
Keywords: Brain tumors, fluoroscopy, radiologist, radiation, medical x-ray, cellular telephones
Introduction
Ionizing radiation is the only established risk factor for brain tumors. The highest risk has been reported for meningioma.[1,2] Recently, 2 cases of brain tumor diagnosed in 1997 among Toronto, Ontario, cardiologists were reported.[3] This might be a chance finding, but since both were occupationally exposed to radiation, a causal association with such exposure could not be excluded.
Some reports have associated pesticides and exposure to certain other chemicals with an increased risk for brain tumors.[1] Based on animal studies, the artificial sweetener aspartame has been discussed as a potential risk factor for especially malignant brain tumors.[4] It was introduced in Sweden in 1981 and is now widely used in different types of food, especially in low-calorie drinks.[5]
Recently, we published results from our case-control study on brain tumors and the use of cellular telephones.[6] For ipsilateral use of a cellular phone, an increased risk was found in the anatomic areas with highest exposure, ie, temporal, temporoparietal, and occipital lobes.
In the same questionnaire, lifetime occupational history and exposure to various agents while working and during leisure time were assessed. These results have not been published so far. Moreover, we have now grouped both sides of anatomic area of the brain and analyzed exposure to mobile phones in relation to the ear used for the calls. The matched control was assigned the same anatomic localization as the corresponding case. Finally, multivariate analysis was performed on risk factors for brain tumor in this study. Thus, in the following, we present further results from the investigation.
| Section 1 of 6 |
|
|||||
References
- Preston-Martin S, Mack WJ. Neoplasms of the nervous system. In: Schottenfeld D, Fraumeni JF Jr. Cancer Epidemiology and Prevention. Oxford, England: Oxford University Press; 1996:1231-1281.
- Soffer, D, Gomori JM, Siegal T, et al. Intracranial meningiomas after high-dose radiation. Cancer. 1989;63:1514-1519.
- Finkelstein MM. Is brain cancer an occupational disease of cardiologists? Can J Cardiol. 1998;14:1385-1388.
- Olney JW, Farber NB, Spitznagel E, Robins LN. Increasing brain tumor rates: is there a link to aspartame. J Neuropathol Exp Neurol. 1996;55:1115-1123.
- Bergsten C. Inntak av kunstige sotstoffer acesulfam K, aspartam, cyklamat och sakkarin [in Norwegian]. Statens naeringsmiddeltillsyn. 1998;4:1-89. Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson Mild K. Use of cellular telephones and the risk for brain tumours: a case-control study. Int J Oncol. 1999;15:113-116.
- Hardell L, Nasman A, Pahlson A, Hallquist A, Hansson Mild K. Use of cellular telephones and the risk for brain tumours: a case-control study. Int J Oncol. 1999;15:113-116.
- Cardis E, Kilkenny M, for the International Study Group. International case-control study of adult brain, head and neck tumours: results of the feasibility study. Radiat Protection Dosimetry. 1999;83:179-183.
- Ron E, Modan B, Boice JD Jr, et al. Tumors of the brain and nervous system after radiotherapy in childhood. N Engl J Med. 1988;319:1033-1039.
- Shore RE, Albert RE, Pasternack BS. Follow-up study of patients treated by x-ray epitalation of tinea capitis: resurvey of post-treatment illness and mortality experience. Arch Environ Health. 1976;31:21-28.
- Colman M, Kirsch M, Creditor M. Tumors associated with medical x-ray therapy exposure in childhood. In: Late Biological Effects of Ionizing Radiation. Vol 1. Vienna, Austria: IAEA(International Atomic Energy Agency); 1978:167-180.
- Eriksson M, Hardell L, Malker H, Weiner J. Increased cancer incidence in physicians, dentists, and health care workers. Oncol Rep. 1998;5:1413-1418.
- Hardell L, Holmberg B, Malker H, Paulsson L-E. Exposure to extremely low frequency electromagnetic fields and the risk of malignant diseases: an evaluation of epidemiological and experimental findings. Eur J Cancer Prev. 1995;4(suppl):3-107.
- Musicco M, Sant M, Molinari S, et al. A case-control study of brain gliomas and occupational exposure to chemical carcinogens: case-control study. Am J Epidemiol. 1982;116:782-790.
- Gurney JG, Pogoda JM, Holly EA, Hecht SS, Preston-Martin S. Aspartame consumption in relation to childhood brain tumor risk: results from a case-control study. J Natl Cancer Inst. 1997;89:1072-1074.
Table 1. Odds Ratios (ORs) and 95% Confidence Intervals (CI) for Ever Employment in Various Occupations.
| Occupation | Cases/Controls | OR (95% CI) |
| Building worker | 15/27 | 1.09 (0.54-2.21) |
| Chemical industry | 9/4 | 4.10 (1.25-13.4) |
| Dressmaker | 6/6 | 1.89 (0.61-5.89) |
| Electrician | 1/12 | 0.16 (0.02-1.20) |
| Electronics work | 15/44 | 0.60 (0.32-1.14) |
| Engineer, technician | ||
| All | 18/42 | 0.80 (0.44-1.45) |
| Chemical work | 2/2 | 1.69 (0.23-12.2) |
| Electronics, telecommunications | 0/9 | . . . |
| Mechanical | 5/9 | 1.05 (0.35-3.16) |
| Technical, other | 7/6 | 2.41 (0.75-7.73) |
| Farmer | 14/35 | 0.68 (0.33-1.41) |
| Laboratory work | 10/6 | 3.21 (1.16-8.85) |
| Lineman | 1/7 | 0.23 (0.03-1.91) |
| Lumberjack | 13/28 | 0.84 (0.41-1.72) |
| Nurse | 5/7 | 1.27 (0.40-4.04) |
| Nurse assistant | 26/40 | 1.25 (0.72-2.17) |
| Painter | 5/16 | 0.60 (0.21-1.70) |
| Plastics work | 6/10 | 1.20 (0.44-3.30) |
| Physician | 3/1 | 6.00 (0.62-57.7) |
| Radar work | 5/8 | 1.25 (0.41-3.82) |
| Sawmill worker | 4/13 | 0.58 (0.18-1.89) |
| Telecommunications work | 25/50 | 0.97 (0.58-1.60) |
Table 2. Physicians' Duration of Work With Fluoroscopy at a Radiology Department
| Sex | Age, y | Year of Exposure/ Duration of Exposure | Diagnosis (Year Diagnosis Made) |
| Female | 51 | 1968, 6 mo | Meningioma (1996) |
| Male | 52 | 1976, 3 mo | Acoustic neurinoma (1996) |
| Male | 56 | 1964-1995 | Oligodendroglioma (1995) |
| Male | 70 | No exposure | Control |
Table 3. Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for Exposure to Different Agents
| Agent | Cases/Controls | OR (95% CI) |
| Asbestos | 9/15 | 1.20 (0.52-2.74) |
| Aspartame* (in light beverage) | 30/45 | 1.24 (0.72-2.14) |
| < 6864 centiliter | 18/21 | 1.64 (0.80-3.38) |
| >/= 6864 centiliter | 12/22 | 1.02 (0.49-2.14) |
| Aspartame,* malignant tumors | 21/25 | 1.70 (0.84-3.44) |
| <6864 centiliter | 10/15 | 1.32 (0.52-3.36) |
| >/= 6864 centiliter | 11/8 | 2.66 (1.01-7.04) |
| Aspartame, benign tumors | 8/15 | 0.96 (0.36-2.54) |
| < 6864 centiliter | 7/5 | 2.93 (0.73-11.7) |
| >/= 6864 centiliter | 1/10 | 0.18 (0.02-1.49) |
| Cutting oils | 5/11 | 0.90 (0.30-2.69) |
| Exhaust (occupational) | 37/76 | 0.87 (0.54-1.39) |
| Fungicides | 0/3 | . . . |
| Glue | 29/43 | 1.37 (0.80-2.38) |
| Herbicides | 13/23 | 1.02 (0.49-2.12) |
| Phenoxyacetic acids | 3/9 | 0.46 (0.10-2.18) |
| Other | 7/7 | 1.64 (0.57-4.75) |
| Impregnating agents | 28/49 | 1.13 (0.69-1.85) |
| Insecticides | 11/28 | 0.74 (0.36-1.49) |
| Oils | 4/5 | 1.60 (0.43-5.96) |
| Organic solvents | 91/160 | 1.15 (0.79-1.68) |
| Smoking, ever | 117/218 | 1.02 (0.72-1.45) |
| Current smoker | 47/94 | 0.94 (0.61-1.46) |
| Ex-smoker | 70/124 | 1.09 (0.72-1.64) |
| Video display unit | 114/196 | 1.28 (0.88-1.86) |
| < 601 Working days | 63/101 | 1.36 (0.88-2.08) |
| >/=601 Working days | 51/95 | 1.20 (0.77-1.87) |
| Occupational use | 99/177 | 1.12 (0.78-1.61) |
| Leisure time use | 53/95 | 1.11 (0.74-1.66) |
*Information on dose missing for 2 controls; histopathologic test results not available for 12 patients.
Table 4. Odds Ratios (ORs) and 95% Confidence Intervals (CIs) for Exposure to Cellular Telephone According to Tumor Localization in Relation to Ear (Side) Used for Cellular Telephone*
| ORs (95% CIs) [Cases/Controls] | |||
| Tumor Localization | Ipsilateral | Contralateral | Ipsilateral and Contralateral |
| Brain, hemisphere | 1.07 (0.64-1.80) | 0.70 (0.39-1.24) | 1.35 (0.57-3.22) |
| [34/59] | [20/54] | [10/12] | |
| Frontal, frontoparietal, parietal, or parieto-occipital | 0.88 (0.45-1.74) | 0.57 (0.26-1.26) | 3.07 (0.89-10.6) |
| [20/41] | [9/31] | [8/4] | |
| Temporal, occipital or temporoparietal | 2.42 (0.97-6.05) | 1.06 (0.42-2.70) | 0.65 (0.13-3.33) |
| [13/12] | [10/19] | [2/6] | |
Table 5. Odds Ratio (ORs) and 95% Confidence Intervals (CIs) for Exposures in a Multivariate Analysis
| Univariate OR (95% CI) | Multivariate OR (95% CI) | |
| Cellular telephone | ||
| (temporal, occipital, or temporoparietal lobe) | ||
| Ipsilateral exposure | 2.42 (0.97-6.05) | 2.62 (1.02-6.71) |
| Contralateral exposure | 1.06 (0.42-2.70) | 0.97 (0.36-2.59) |
| Ipsilateral/contralateral exposure | 0.65 (0.13-3.33) | 0.71 (0.14-3.68) |
| Laboratory work | 3.21 (1.16-8.85) | 8.81 (0.96-80.7) |
| Medical diagnostic x-ray investigations, head and neck | 1.64 (1.04-2.58) | 1.66 (0.75-3.65) |
Medscape General Medicine. 2000;2(2) © 2000 Medscape